- Report
- January 2024
- 142 Pages
United States
€3440EUR$3,800USD£2,947GBP
- Training
- 3 Hours
Global
€1208EUR$1,381USD£1,000GBP
- Training
- December 2026
- 3 Hours
Europe
€423EUR$483USD£350GBP
€483EUR$553USD£400GBP
- Newsletter
- July 2026
- 16 Pages
United States
- Newsletter
- July 2026
- 12 Pages
Germany
- Newsletter
- July 2026
- 12 Pages
France
- Newsletter
- July 2026
- 13 Pages
United States
- Newsletter
- July 2026
- 13 Pages
Italy
- Newsletter
- July 2026
- 15 Pages
United Kingdom
- Newsletter
- July 2026
- 11 Pages
United States
-
Journal - July 2026
Global
From €385EUR$425USD£330GBP
- Newsletter
- July 2026
- 5 Pages
Global
From €119EUR$131USD£102GBP
- Newsletter
- July 2026
- 4 Pages
Global
From €181EUR$200USD£155GBP
- Report
- April 2026
- 115 Pages
South Africa
From €1982EUR$2,190USD£1,698GBP
- Report
- February 2026
- 22 Pages
South Korea
From €4522EUR$4,995USD£3,874GBP
- Report
- February 2026
- 22 Pages
Italy
From €4522EUR$4,995USD£3,874GBP
- Report
- February 2026
- 22 Pages
India
From €4522EUR$4,995USD£3,874GBP
- Report
- February 2026
- 22 Pages
Germany
From €4522EUR$4,995USD£3,874GBP

The Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and commercialization of drugs and treatments for specific medical conditions. It is composed of a wide range of companies, from large multinationals to small start-ups, all of which are dedicated to researching and developing treatments for a variety of diseases and medical conditions. These companies are typically involved in the research and development of new drugs, as well as the marketing and distribution of existing drugs.
Some of the major players in the Therapeutic Area market include Pfizer, Merck, Novartis, GlaxoSmithKline, Sanofi, AstraZeneca, Johnson & Johnson, Bristol-Myers Squibb, and Eli Lilly. These companies are involved in the development of treatments for a variety of medical conditions, including cancer, cardiovascular disease, diabetes, and infectious diseases. Additionally, many of these companies are also involved in the development of treatments for rare diseases and orphan drugs. Show Less Read more